Sunday, April 23, 2006

BEST PRACTICES FROM TREATMENT IMPROVEMENT PROTOCOL 43: Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs

TIME: 9:00 AM – 12:00 PM

Ron Jackson, MSW
Evergreen Treatment Services
Seattle, WA

Karol Kaltenbach, PhD
MATER-Thomas Jefferson University
Philadelphia, PA

Judith Martin, MD
14th Street Clinic
Oakland, CA

These preconference sessions will be three consecutive 1-hour presentations based on topics from Treatment Improvement Protocol (TIP) 43: Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs. The Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Treatment (CSAT) produced TIP 43 to provide best-practice guidelines for the treatment and maintenance of individuals who are dependent on opioids. This TIP provides a detailed description of medication-assisted treatment (MAT) for opioid addiction in opioid treatment programs. It includes information on comprehensive treatment, medication maintenance, dosing, assessment, treatment planning for opioid addiction, and co-occurring medical and psychiatric conditions.

The three sessions are:
Tips for Counselors: Patients With Medical Problems—This session will be presented by Dr. Martin. Participants who attend this presentation will be familiar with the medical problems that are common in people who are addicted to opioids, understand the treatment of these problems in OTPs, be able to determine when to refer people to outside services and know the counselor’s role in providing supportive care for these patients.

Treating Pregnant Women in Opioid Treatment Programs—This session will be presented by Dr. Kaltenbach. Participants who attend this presentation will understand the benefits of MAT for pregnant women who are opioid addicted, be familiar with the symptoms of opioid dependence in pregnant and postpartum women, and understand methadone dosing and management for pregnant women and postpartum mothers receiving MAT.

Updates on Buprenorphine and Methadone Treatment of Opioid Addiction—This session will be presented by Mr. Jackson. Participants who attend this presentation will understand the current research on the safety and effectiveness of MAT and learn about the pharmacology and clinical use of methadone and buprenorphine.

Copies of TIP 43 will be provided to every participant, and the TIP will be used as the textbook for all three sessions.

Supported by the SAMHSA/CSAT.